On October 27, 2025, BridgeBio Pharma announced positive topline results from its pivotal Phase 3 FORTIFY study for BBP-418 in individuals with limb-girdle muscular dystrophy type 2I/R9, achieving all ...
Stop muscle loss with 5 daily standing moves that train deep stabilizers, improve posture, and build strength after 50.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback